Early research (Phase 1)Study completedNCT00251368
What this trial is testing
Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
Who this might be right for
Leukemia, Myelocytic, AcuteAcute Lymphocytic Leukemia
Dana-Farber Cancer Institute 52